Triamcinolone + Nystatin Rx
Generic Name and Formulations:
Triamcinolone acetonide 0.1%, nystatin 100000units/g; crm; oint.
Various generic manufacturers
Indications for Triamcinolone + Nystatin:
Adults and Children:
Apply sparingly 2 times daily; max 25 days treatment.
Avoid prolonged use or on large areas. Use lowest effective dose (esp. in children). Do not occlude. Discontinue gradually in chronic use. Discontinue if superinfection or irritation occurs. Reevaluate if no improvement after 25 days. Pregnancy (Cat.C). Nursing mothers.
Steroid + polyene antifungal.
Local irritation, folliculitis, hypertrichosis, dermatitis, sensitization, HPA axis suppression (esp. in children), epidermal and dermal atrophy (esp. in thin-skinned or occluded areas).
Formerly known under the brand names Myco-triacet II, Mycolog II, Mytrex F.
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally